MACROGENICS INC · Drugmakers

MGNX

Moderate riskNext report: Around Nov 11 (est.)

View price ↗

The short version

A company still losing money with steady sales, with elevated risk. Institutions are adding.

Watch out for

About 8 months of cash left at its current burn
Losing money

Money moves

No insider buying or selling in the last 30 days
Institutions added 13% to their holdings in the quarter ending June 2026 (72 bought, 54 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$2.19-2.7% that day

Company value: $140M; Share price times all shares
Price vs sales: 0.83x; No profit over the last year, so this compares value with sales instead
Cash vs value: 82%; A big cushion: cash is a large part of what the company is worth

From MGNX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$32.8M+378% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $167.7M, up 12% from the 12 months before. Over 5 years, sales grew about 7.3% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of MGNX. Starting points are the company's recent numbers.

Sales growth+12% a yearRecently: +12% a yearProfit margin36%Last 12 months: 35.8%P/E at the end15xMany steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$295M

Profit in 5 years$106M

Price these guesses point to$23.83+988% vs $2.19 todayAbout +61% a year, before dividends

What today's price needs: with a 36% margin and a 15x P/E, sales could shrink about 31% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/5Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-0.1%
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.0%
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$83.0M
MissShare count not growingNot diluting owners. Falling means buybacks.+2.8% in 3 years

Revenue: $149.5M; -0.3% vs prior year
5-year growth: +7.3%/yr; revenue, per year
Current ratio: 5.10x; short-term assets / bills due
Free cash flow: -$83.0M; -55.5% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 13

Revenue: $32.8M; +378.0% YoY
EPS: $0.31; vs -$0.57
Op. margin: -42.2%; +587.1 pts
Free cash flow: -$41.6M
Share count: +0.7%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

63/ 100

This week: 2
Normal week: 1.2
vs normal: 1.7x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+12.8%

Institutions added 12.8% to their holdings. 72 bought, 54 sold. 2 quarters of net buying in a row.

Shares held by institutions48.7M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+0.9%

Cash runwayAt last year's cash burn

17 months

Debt to equityLatest balance sheet: debt compared with what owners have

Total liabilities $302.5M

Shares outstandingLatest reported

64M

Why moderate risk

Losing money, losses are large next to sales
About 17 months of cash left at its current burn

Earnings reports

Last 12

Next reportAround Nov 11 (est.)Estimated from the same quarter last year

Results filedAug 13
Results filedMay 13
Results filedMar 9
Results filedNov 12, 2025
Results filedAug 14, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Aug 14 · View filing ↗Big holder 5%+ holder update (passive)Aug 3 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Other company newsOct 23 · Form 8-K ↗Planned insider saleOct 22 · Form 144 ↗

Option exerciseEzio BonviniSr VP, Research & CSO

8,000 shares at $2.60 · $21K

+4% of holdings
Now owns 193,799 shares
Exercise price $2.60
Filed 1 day after trade

Oct 6Form 4 ↗

Planned insider saleSep 21 · Form 144 ↗Current reportSep 3 · Form 8-K/A ↗Employee stock plan registrationSep 3 · Form S-8 ↗

SoldJeffrey Stuart PetersSenior VP, GC, and Secretary

31,105 shares at $4.15 · $129K

-100% of holdings
Owns no shares after
Pre-planned sale (10b5-1)
Filed 1 day after trade

Aug 19Form 4 ↗

Planned insider saleAug 19 · Form 144 ↗

Option exerciseEzio BonviniSr VP, Research & CSO

40,000 shares at $2.60 · $104K

+27% of holdings
Now owns 185,799 shares
Exercise price $2.60
Filed 1 day after trade

Aug 17Form 4 ↗

Planned insider saleAug 17 · Form 144 ↗5%+ holder update (passive)Aug 14 · Form SCHEDULE 13G/A ↗Quarterly reportAug 14 · Form 10-Q ↗Earnings resultsAug 13 · Form 8-K ↗5%+ holder update (passive)Aug 3 · Form SCHEDULE 13G/A ↗Planned insider saleAug 3 · Form 144 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page